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Background: CpG dinucleotide-rich genomic DNA regions, known as CpG islands (CGIs), can be methylated at
their cytosine residues as an epigenetic mark that is stably inherited during cell mitosis. Differentially methylated
regions (DMRs) are genomic regions showing different degrees of DNA methylation in multiple samples. In this
study, we focused our attention on CGIs showing different DNA methylation between two culture replicas of
the same cell line.
Results: We used methylation data of 35 cell lines from the Encyclopedia of DNA Elements (ENCODE) consortium
to identify CpG islands that were differentially methylated between replicas of the same cell line and denoted
them Inter Replicas Differentially Methylated CpG islands (IRDM-CGIs). We identified a group of IRDM-CGIs that
was consistently shared by different cell lines, and denoted it common IRDM-CGIs. X chromosome CGIs were
overrepresented among common IRDM-CGIs. Autosomal IRDM-CGIs were preferentially located in gene bodies
and intergenic regions had a lower G + C content, a smaller mean length, and a reduced CpG percentage.
Functional analysis of the genes associated with autosomal IRDM-CGIs showed that many of them are involved
in DNA binding and development.
Conclusions: Our results show that several specific functional and structural features characterize common
IRDM-CGIs. They may represent a specific subset of CGIs that are more prone to being differentially methylated
for their intrinsic characteristics.
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DNA methylation is an epigenetic mechanism involved
in transcriptional regulation and chromatin remodelling
[1]. It occurs on cytosine residues at CpG dinucleotides,
which are the target of three DNA methyltransferases,
DNMT1, DNMT3a, and DNMT3b, which add a methyl
group to form 5-methylcytosine [2]. Genomic regions
with a high CpG density are known as CpG islands
(CGIs) [3]. It has been suggested that CGI methylation
influences the regulation of gene expression [4,5].
The epigenome is considered mitotically stable, meaning
that cells undergoing mitosis maintain their epigenetic* Correspondence: icastald@unina.it
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reproduction in any medium, provided the orcontent [6]. The stability of mechanisms involved in
the propagation of DNA methylation during somatic
cell divisions is crucial to the preservation of cellular
identity and the maintenance of specific gene expression
patterns for each cell type. The molecular mechanisms
of DNA methylation mitotic stability have not been
fully elucidated, although the high affinity of the DNMT1
protein complex for hemi-methylated DNA appears to be
involved in this process [7]. Similarly, the means by which
other epigenetic marks, such as histone modifications,
are preserved during cellular division is also poorly
understood [8].
However the epigenome shows also a good degree of
flexibility. Cells must be able to respond quickly and
accurately to environmental changes, and epigenetic
changes play a role in this adaptability. It has been
demonstrated that environmental factors includingl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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modify the cell epigenetic status [9].
Differentially Methylated Regions (DMRs) are genomic
regions that show differences in DNA methylation between
multiple samples, including different tissues, cells, or
individuals. DMRs are found in different developmental
stages (D-DMRs), across multiple tissues (T-DMRs)
and between cancer and normal cells (C-DMRs) [10-12].
When the genomic regions under analysis are CGIs, the
term “differentially methylated CpG islands” (DM-CGIs)
can be used.
In this paper, we investigated the stability of CGI
methylation during in vitro cell culture. In particular,
we focused on DM-CGIs found in culture replicas of
the same cell line. Although culture conditions, including
medium composition, temperature, CO2%, and cell-cell
interactions, are standardized and the cell micro-envir-
onment is expected to be the same across replicas, it is
likely that marginal changes happen by chance. In light
of these considerations, we studied the variation in CGI
methylation between replicas of 35 cell lines. We used
publicly available data provided by the Encyclopedia of
DNA Elements (ENCODE) consortium [13]. As expected,
we found that most CGIs showed similar DNA methy-
lation values between the two replicas. We focused
our attention on the minority of CGIs with different
DNA methylation levels between the two replicas. The
CGIs showing this behaviour in a cell line were found
differentially methylated also in other cell lines more
frequently than expected by chance. Furthermore, we
found that several functional and structural specific
features characterize these CGIs.Results
Evaluation of CpG island methylation and calculation of
the correlation between replicas
For CpG island definition and localization, we used the
UCSC Genome Browser CpG island track (Cpg Island
Ext track). CpG methylation data from 35 cell lines
produced by the ENCODE consortium [13] were
downloaded from the UCSC Genome Browser (http://
genome.ucsc.edu, “HAIB Methyl RRBS” track) [14].
Data for two replicas are available for each cell line
within this repository. To compare different cell lines,
we restricted our analysis to CGIs in which methylation
data were present in both replicas only. In order to define
a reliable methylation level for a CGI we considered
its CpGs with a read coverage ≥ 10 only. These cell
lines belonged to three groups: cancer transformed
cells (n = 10), EBV transformed cells (n = 5) and normal
untransformed cells (n = 20). Additional file 1: Table S1
shows the list of the cells used and their features. To
estimate the level of DNA methylation of each CGI,we calculated the mean methylation values of all CpGs
located within a CGI.
Identification of inter replicas differentially methylated
CpG islands
As expected, we observed a good correlation between
the two replicas for each cell type using the Pearson
correlation (mean = 0.97). To identify CGIs that were
differentially methylated between two replicas of the
same cell line, we have sequentially applied two methods:
Quantitative Differentially Methylated Region (QDMR)
and Hypergeometric Based Approach (HBA). The first
is a quantitative method that identifies differentially
methylated regions using an entropy-based algorithm
[15] (see Methods). HBA is a method able to test the sta-
tistical significance of possible differences in the methyla-
tion levels between two replicas of a particular genomic
region. QDMR is particularly sensitive to the absolute
difference in the methylation level of two replicas con-
sidered while HBA is particularly sensitive to the read
coverage and the amount of CpGs contained in the
CGI considered (see Methods).
We defined as Inter Replicas Differentially Methylated
CpG Islands (IRDM-CGIs), the CGIs that were classified
by both methods as differentially methylated. Such con-
servative approach has the advantage to take simultan-
eously into account the read coverage and the CpG
content of the considered CGI, and the difference in the
methylation values measured in the two replicas.
By using sequentially these two methods we observed
an average of 439.5 IRDM-CGIs per cell line (range,
109-913). No statistically significant differences were
noted in the number of IRDM-CGIs between cancer,
EBV and normal cell lines using Welch’s one-way analysis
of means test (p = 0.262).
IRDM-CGIs are similar across different cell lines
Since we expected that the same CGI be methylated to
the same extent in two replicas of the same cell line, a
reasonable hypothesis to explain the presence of IRDM-
CGIs is that they occur by chance. Under this null
hypothesis, any CGI should have the same probability
to become an IRDM-CGI in different inter-replica
comparisons. Alternatively, it could be hypothesized that
some CGIs are more prone to becoming IRDM-CGIs than
others. In this case, the same IRDM-CGIs should be found
in all cell lines.
To distinguish between these two hypotheses, it is
useful to define as “overlap degree” the number of different
cell lines in which the same CGI is classified as IRDM-CGI.
By definition the minimal value 1 corresponds to a CGI
that has been classified as IRDM in one cell line only.
Figure 1 shows the observed overlap degree distribution.
We compared such distribution with the corresponding
Figure 1 Distribution of IRDM-CGIs’ overlap degree. Figure 2 Comparison of chromosome distributions between
common IRDM-CGIs and all CGIs. Gray bars represent the
proportion of common IRDM-CGIs for each chromosome, while
black bars represent the proportion of all CGIs.
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assignments of the status of IRDM-CGIs to the CGIs of
the considered cell lines (see Methods and Additional file 2:
Figure S1). A statistically significant difference (p <
2.2 × 10-16) was found between the observed and si-
mulated distributions (Additional file 2: Figure S1),
indicating that the same IRDM-CGIs are present in
different cell lines more frequently than expected by
chance. For the analysis reported in Additional file 2:
Figure S1 only CGIs belonging to the intersection have
been used.
Considering all the IRDM-CGIs analysed, we denoted
those present in at least two cell lines as “common
IRDM-CGIs”. We found that they represent more than
half of the IRDM-CGIs. Specifically, 2772 out of 5537
IRDM-CGIs were present in at least two different cell
lines. In the Additional file 3: Table S2 we report for
each IRDM-CGI its localization, the set of cells in which
it was found as IRDM and its overlap degree.
Overrepresentation of common IRDM-CGIs on
chromosome X
We asked if common IRDM have a specific chromosomal
localization.
In Figure 2, the proportion of common IRDM-CGIs
within a particular chromosome (grey bars) is compared
with the proportion of all considered CGIs (black bars)belonging to the same chromosome. Interestingly, we
found a striking overrepresentation of common IRDM-
CGIs on chromosome X. Specifically, 401 out of all 606
CGIs analyzed on chromosome X (66%) were common
IRDM-CGIs, representing ~5-fold increase of the observed
versus expected values (p < 10-4). We tested this difference
using a bootstrap approach and in all Monte Carlo
simulations no simulated frequency value higher than
the observed one was observed for chromosome X. To
avoid eventual biases in the following analyses from
this overrepresentation, we analyzed autosomal IRDM-
CGIs and chromosome X IRDM-CGIs separately.
Autosomal common IRDM-CGIs are preferentially located
in gene bodies and intergenic regions
CGIs can be found in different gene regions (5′, 3′, intra-
genic and intergenic regions) throughout the genome.
To test whether common IRDM-CGIs are preferentially
located in specific gene regions, we used the four classes
of CpG islands described by Medvedeva et al. [16]: 5′
CGIs, intragenic CGIs, 3′ CGIs, and intergenic CGIs.
Compared with the other autosomal CGIs, autosomal
common IRDM-CGIs were less frequently located at
the 5′ end of genes and were most frequently located
in intragenic, 3′, and intergenic regions (chi-square test
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localization were found for chromosome X IRDM-CGIs
(data not shown).
Functional analysis of genes associated with autosomal
common IRDM-CGIs
We next investigated whether common IRDM-CGIs are
associated with genes sharing common functions. We
searched for the overrepresentation of Gene Ontology
(GO) annotation terms [17] in the set of genes associated
with IRDM-CGIs. To perform this analysis we used
the Genomic Regions Enrichment of Annotations Tool
(GREAT) [18]. Concerning autosomal common IRDM-
CGIs, we found one term that is statistically significant
enriched in our sample (Hypergeometric Test: FDR
Q-Val = 0.00033). This term (Sub Ontology =Molecular
Function; GO: 0000976 – Transcription regulatory region
sequence-specific DNA binding) includes genes inter-
acting selectively with a specific sequence of DNA that
controls transcription (Additional file 4: Table S3).
To analyze whether autosomal IRDM-CGIs with higher
overlap scores represent a more homogenous group inside
IRDM-CGIs, we selected the 154 autosomal common
IRDM-CGIs that were present in at least seven differentFigure 3 Autosomal common IRDM-CGIs are preferentially
located in intragenic, 3′ and intergenic regions. The percentages
of autosomal CGIs falling in each category of gene regions, as
defined by Medvedeva et al., are shown. White bars represent the
relative proportion of common IRDM-CGIs for each gene region,
while black bars represent the relative proportion of all CGIs.inter-replica comparisons (corresponding to the highest
5% of autosomal common IRDM-CGIs’ distribution),
hereafter designated “most common IRDM-CGIs”. The
HUGO Gene Nomenclature Committee (HGNC, www.
genenames.org) Gene Families analysis, performed by
GREAT, showed that this subset of IRDM-CGIs was
enriched for genes belonging to the Zinc fingers, C2H2-
type gene family (ZNF) (Additional file 4: Table S3),
with 16 out of 154 being located in genomic regions
containing ZNF genes (Hypergeometric Test: FDR Q-
Val = 2.22 × 10-5). Furthermore, analysis of The Mouse
Genome Informatics (MGI) Phenotype ontology [19] by
GREAT showed that this subset of autosomal common
IRDM-CGIs is enriched for genes involved in genetic
imprinting (Additional file 4: Table S3). No enrichments
were found for chromosome X IRDM-CGIs (data not
shown).
Autosomal common IRDM-CGIs have a low G + C content
As a next step, we searched for structural features of
common IRDM-CGIs. We found that autosomal common
IRDM-CGIs had a lower G + C content compared with
the autosomal not IRDM-CGIs using the t-test (mean =
0.6848862 vs. 0.6966308; p < 2.2 × 10-16). Moreover, the
G + C content was very similar to that obtained from
chromosome X CGIs (data not shown). This last finding is
not unexpected, since it is known that chromosome X has
a low G + C content compared with autosomal regions
[20]. We also found significant differences in mean length
and CpG percentage of common IRDM-CGIs compared
with autosomal not IRDM-CGIs, namely 580 bp vs.
910 bp (p < 2.2 × 10-16) and 0.79 vs. 0.84 (p < 2.2 × 10-16)
respectively.
Autosomal IRDM-CGIs are enriched among inter cell line
differentially methylated CGIs
Since the 35 cell lines analyzed belong to different
tissues and to different categories (normal, EBV trans-
formed and cancer), we expected that, when we search
for DM-CGIs among these cell lines, many genomic
regions differ in their methylation status.
We tested the hypothesis that the set of autosomal
IRDM-CGIs were related with the set of CGIs differentially
methylated among the different cell lines (ICDM-CGIs).
To this aim we firstly identified, by QDMR, the CGIs
that were differentially methylated among different cell
lines (hereafter denoted by ICDM-CGI). We identified
3814 ICDM-CGIs out of 11668. Then we determined the
degree of overlap between IRDM-CGIs and ICDM-CGIs.
We found a significant enrichment of IRDM-CGIs in the
ICDM set. About 70% of all considered IRDM-CGIs are
ICDM-CGIs as well (Fisher’s Exact test p < 2.2 × 10-16).
Analogous enrichments were found restricting the analysis
to common and most common IRDM-CGIs (Additional
file 5: Table S4).
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Several pieces of evidence suggest that somatic cells
modify their DNA methylation status more often than
once thought. It has been hypothesized that variations in
DNA methylation can occur in response to environmental
stimuli [21]. It has also been hypothesized that several
changes can occur only by chance. The term “epigenetic
drift” is used to indicate small faults in transmitting
epigenetic information through successive cell divisions,
or preserving it in differentiated cells. Accumulation of
these epigenetic defects is probably associated with the
aging process [22].
Previous studies revealed different epigenetic modifi-
cations that occurred during cell culture [23,24]. In this
study, we tested the hypothesis that several genomic
regions are more prone to undergoing epigenetic
remodelling than others. We used a genome-wide
approach, evaluating the differences in methylation
of the same CGIs between replicas of the same cell
line. Our working hypothesis was that minimal stochastic
changes, which are likely to happen in cell culture, could
slightly modify the extent of DNA methylation of several
genomic regions, unmasking CGIs that are more prone
to modifying their methylation states in response to
small environmental stimuli.
Overall, we found a good correlation among methylation
values of the same CGIs between two replicas of the
same cell line. This finding was expected, and confirmed
the well-known notion that the epigenome is mitotically
stable. Major epigenetic changes during mitosis of somatic
cells could be catastrophic for the organism, and we did
not expect dramatic modifications. Nevertheless, we found
that some CGIs escape this general rule, showing slightly
different methylation values between the two replicas.
A possible explanation for this phenomenon is that it
happens only by chance. In this case, the prediction
would have been that these CGIs are typically different
in each comparison. On the contrary we found that,
frequently, the same IRDM-CGI was present in different
comparisons performed between different cell pairs.
The overlaps between IRDM-CGIs sets extracted from
different pair comparisons were very large, and statistical
tests suggested that this was very unlikely to have occurred
by chance. Thus, a limited number of CGIs appear to be
differentially methylated between replicas, in a way that
is independent from the type of analyzed cell line as
the 35 cell lines used in this study belong to different
groups in terms of tissue origin and transformation status.
Therefore, our data suggest that IRDM-CGIs are prone to
being differentially methylated for their intrinsic character-
istics that are independent of the cell environment.
Further evidence in support of the observed pheno-
menon not being caused by chance alone is the strong
enrichment of IRDM-CGIs located on chromosome X. Wefound that most chromosomes X CGIs were differentially
methylated between replicas. It is well known that
chromosome X undergoes a specific form of epigenetic
modification, as X-inactivation [25], and that it has a low
G + C content compared with autosomes [20].
Autosomal common IRDM-CGIs were found to be
preferentially located in intragenic, 3′ and intergenic
regions. While the role of DNA methylation of CGIs
located in 5′ promoters is well established [26], the effect
of DNA methylation on gene bodies and intergenic
regions is less clear. Nevertheless, intragenic methylation
plays a role in regulating alternative promoters in gene
bodies [26]. It has also been reported that imprinted
genes contain a higher proportion of intragenic CpG
islands [27] and that inter and intragenic CGIs are
more susceptible to methylation [28].
Furthermore, our results demonstrated that regions near
autosomal IRDM-CGIs are enriched in genes involved in
DNA binding, development and embryonic morphogen-
esis. Illingworth et al. [28] noted that differentially methyl-
ated CGIs preferentially include genes that play central
roles in development, such as homeobox (HOX) genes,
paired box (PAX) genes and their relatives [29].
Developmental genes show distinctive epigenetic features.
DNA binding factors and other development-related genes
show a bimodal distribution of CpG usage, in methylated
genomes only, and are noticeably overrepresented in or
near clusters of three or more CGIs. The expansion of
distinct chromatin blocks was found to selectively affect
developmental genes in fibroblasts compared with human
embryonic stem cells (hESCs) [30]. In addition, Heyn et al.
recently described the differences in DNA methylation
between newborns and centenarians [31]. Their search for
GO enrichments in these differentially methylated genes
led to the conclusion that age-related hyper-methylated
CpG sites are located preferentially in developmental
and morphogenesis-related genes. A similar age-related
enrichment was also found in the mouse [32]. It is possible
that the increased susceptibility to DNA methylation
changes we observed in cell culture could be related
to those DNA methylation changes that occur during
a lifetime.
We also analyzed the most common IRDM-CGIs (cor-
responding to the top 5-percentile of the distribution)
and found a strong enrichment for ZNF genes. Previous
findings suggest that ZNF genes represent a separate
epigenetic group [11] that is characterized by H3K9me3
and H3K36me3 dual occupation and low CpG density in
the gene bodies. These features were also associated with
a group of genes found to be activated in conditions of
DNMT deficiency [11].
We did not expect that the differences in DNA methy-
lation that we found between replicas correspond to
relevant changes in gene expression, since this could be
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To roughly evaluate possible transcriptional effects related
to IRDM-CGIs, we analyzed between-replicas differences
in the expression of the same mRNA. We could study only
the subset of 12 cell lines whose expression data were
available in the UCSC ENCODE Exon Array Tracks
(see Methods). By using GREAT, we grouped mRNAs
according to their proximity to IRDM-CGIs or to not
IRDM-CGIs (see Methods). We calculated, for each
transcript, the absolute value of the relative difference of
mRNA levels between the two replicas and we denoted it
as DR (see Methods). Then, we evaluated if DR was dif-
ferently distributed in IRDM-CGIs vs. not IRDM-CGIs
related genes and we did not find significant differences
(data not shown). This finding seems to suggest that
the difference in DNA methylation that we found does
not affect mRNA transcription. Nevertheless we are
aware of the limits of such approach, which can only
provide a rough estimation of the mRNA differences
between the replicas and that is not able to exclude that
minimal changes in mRNA expression exist.
We found a significant overlap between CGIs that are
differentially methylated between replicas and those that
are differentially methylated among different cell lines. It
is possible to speculate that proneness of IRDM-CGIs to
change their methylation status also not having a relevant
functional impact between replicas (i.e. great differences in
transcription), but it could facilitate methylation changes
during cell differentiation and/or transformation.
Conclusions
DNA methylation in cultured cell lines is subject to small
modifications, probably from minimal stochastic changes
in culture conditions. Here, we describe the character-
ization of differently methylated CGIs from 35 replicas
of three different cell types. Our results show that
IRDM-CGI sets are similar in different cell types and
are characterized by several functional and structural
specific features. We speculate that they represent a
specific subset of CGIs that are more prone to undergoing
differential methylation because of their intrinsic characte-
ristics. However, our study is only a preliminary exploration
and further studies are required to confirm that CGIs differ
in their innate susceptibility to methylation.Methods
Quantitative differentially methylated region
(QDMR) method
As first step we have selected the only CpGs with a
number of reads ≥ 10 (to exclude poorly covered
regions). To determine the CGI methylation value we
computed the mean of the methylation level of CpGs
located inside the CGI.To quantify differences in the methylation level of the
same region across many samples it has been used the
Quantitative Differentially Methylated Region (QDMR)
method, developed in [15]. Such procedure is based on
Shannon entropy,





with mr,s denoting the methylation level of region r in the
sample s. The lower H0 is the greater the methylation
difference among samples. However, since H0 is biased to-
ward specific high values in small samples, it is convenient
to use a robust weighted mean which is insensitive to out-
liers, like a one-step Tukey's Biweight =Σs = 1
N [w(ur,s) mr,s]/
Σs = 1
N w(ur,s), where the weight w(ur,s) of each level mr,s is re-
duced by a function of its distance from the median of
measurements.
By using Tbr, one can replace in the expression of H0
the methylation levels mr,s with their distances from Tbr,
namely mr,s→m ’ r,s = |mr,s −Tbr|. In this way one can
define HP = −Σs = 1
N p ’ s/rlog2(p ’ s/r), whereas p ’ s/r = m ’ r,s/
Σs = 1
N m ’ r,s done in ROKU method [33]. Unfortunately,
even such a method has problems since it assigns the
same entropy to different regions with the same relative
levels of methylation, even if they have different absolute
levels of methylation. In order to avoid such a problem
the entropy of each region can be adjusted by using
the weight




= MAX−MINð Þ þ ε 
where max(mr,s) and min(mr,s) are the maximum and
minimum methylation levels across s samples of region r,
respectively, and MAX and MIN the bounds of their pos-
sible values (1 and 0, typically). The quantity ε is an arbi-
trary small number able to regularize the expression. By
using such a weight the adjusted entropy becomes
HQ ¼ HP  wr
The entropy so defined is vanishing for regions diffe-
rentially methylated in a single sample, and takes the
maximum values fin case of uniform methylation levels
across samples.
In terms of HQ, a Region is Differentially Methylated
(DMR) if its HQ value is smaller than a certain threshold.
Such threshold is determined by using a simulation of the
entropy distribution coming from uniformly methylated
regions where a level of intrinsic biological variation,
parameterized by the SD of the methylation level, is
assumed. In this analysis, the parameter SD = 0.03
was chosen such that all DMR standard deviations
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values in the case of two replicas) are located in the top
5-percentile.Hypergeometric based approach (HBA)
The methylation level estimation from RRBS data is ge-
nerally affected by read coverage, which can vary among
the different CpGs contained in a CGI. In addition, in
our approach, the number of CpG tested in that CGI
could affect the evaluation of the CGI methylation mean
value. For this reason it is crucial to define a measure of
the statistical significance of the observed differences
that takes in account these two possible biases. To
perform such a test, we used an approach inspired to
the one presented in [34]. As first step, we considered
only CpGs whose read coverage is ≥ 10 (to exclude
CpGs too poorly covered). For each CpG we counted
in how many reads, for each replica, it was reported as
methylated. Then, for each CGI in each of the two
replicas, the values associated to each CpG, were
summed together to obtain the CGI’s global methylation
value. In this way, this global value depends on both the
read coverage and the CpG content of the CGI. Finally
for each CGI we can fill a contingency matrix that allows
for an exact Fisher’s test. Also in this case, we consistently
assumed as threshold of statistical significance of 5%.
Filtering with HBA the CGIs classified as differentially
methylated by QDMR reduces on average their number
of about 20%.Differences in IRDM-CGI content among various cell types
Differences in the mean content of IRDM-CGIs between
cancer, EBV and normal cell lines were tested using
Welch’s one-way analysis of means test. To test the null
hypothesis that IRDM-CGIs are determined only by chance,
the overlap distribution obtained from the experimental
data was compared with the analogue quantity obtained
by 100 Monte Carlo simulations under this null hypothesis
(Additional file 2: Figure S1).
We estimated the difference between these two distribu-
tions by testing whether IRDM-CGIs present in at least
two cell lines were overrepresented in our dataset. In
particular, Fisher’s exact test was performed on a 2 × 2
contingency table containing the number of IRDM-CGIs
present in one cell line and the number of IRDM-CGIs
shared by more than one cell line for both observed and
simulated data (p < 2.2 × 10-16). For this last analysis only
CGIs belonging to the intersection have been used.
The above-mentioned p-value represents the upper
boundary of the global error associated with the deviation
of the actual distribution from the simulated one.
Performing the same test on the tables associated with
IRDM-CGIs shared by more than two cell lines will givelower p-values because of the exponential behaviour of
the null distribution (see Additional file 2: Figure S1).Distribution of IRDM-CGIs across chromosomes
To test the null hypothesis that IRDM-CGIs are randomly
distributed across chromosomes, we used a bootstrap
approach. Specifically, we compared the observed dis-
tribution in chromosomes of IRDM-CGIs with the one
expected by chance. The latter distribution was obtained
from a large number (104) of randomly sampled distribu-
tions of the same number of IRDM-CGIs.Distribution of IRDM-CGIs in gene regions
We tested for differences in the location of IRDM-CGIs by
subdividing them according to their locations. Specifically,
we used the classification system described previously
by Medvedeva et al. [16], in which CGIs are classified
according to their locations. Thus, CGIs were classified
into four classes: (1) 5′ CGIs are located in the 5′ flanking
region, the 5′ UTR-exon, the 5′ UTR-intron, the initial
coding exon or the initial intron. CGIs in the 5′ flanking
regions were predominantly located in regions from 3 kb
upstream of the translational start site to the first intron.
(2) Intragenic CGIs are located in the internal exons
and introns. (3) 3′ CGIs are located in the final exon,
the final intron, the 3′ UTR-exon or the 3′ UTR-intron.
(4) Intergenic CGIs are located at least 3 kb upstream or
downstream from any known gene.
We tested the relationship between IRDM-CGIs and
their positions using the Pearson’s Chi-square test. We
performed separate analysis for autosomal and non-
autosomal IRDM-CGIs, and observed significant dif-
ferences in localization only for autosomal IRDM-CGIs
(p < 10-20).Functional characterization
Putative target genes of common IRDM-CGIs were found
using the Genomic Regions Enrichment of Annotations
Tool (GREAT version 2.02) [14] using the default asso-
ciation rule (Species assembly: hg19 Association rule:
Basal + extension: 5,000 bp upstream, 1,000 bp down-
stream, 1,000,000 bp max extension, curated regulatory
domains included). All enrichment estimations were
performed by GREAT. This tool performs the binomial
test over genomic regions and the hypergeometric test
over genes for several ontologies to provide an accurate
picture of annotation enrichments for genomic regions.
For both tests GREAT calculates a “row value” and a
False Discovery Rate Q-Value for a threshold of 0.05. In
our analysis we considered only those enrichments that
were significant for both tests.
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To determine the structural features of IRDM-CGIs, we
computed the G + C content for each autosomal CGI and
each X chromosome CGI. We then compared the mean
C + G content between common autosomal IRDM-CGIs
and the autosomal not IRDM-CGIs using a two-sided
t-test.
RNA expression analysis
To evaluate possible transcriptional effects related to
IRDM-CGIs we considered expression data available in
the ENCODE repository for the analyzed cell lines.
Expression data are available only for 12 of the 35 cell
lines used for the methylation analysis (Fibroblasts,
Gm12878, Gm12891, Gm12892, Gm1239, Gm19240,
H1hesc, HelaSS4, Hepg2, HMEC, HSMMtube, K562).
Therefore we considered only them and we downloaded
expression data (expr1 and expr2) of two replicas from
the UCSC ENCODE Exon Array Tracks.
By using GREAT, we recovered for each cell line two
set of genes: one associated to the IRDM-CGIs (IRDM-G)
and one associated to the not IRDM-CGIs (N-IRDM-G).
We filtered expression data of both replicas for IRDM-
G and N-IRDM-G, obtaining, for each cell lines, two
distributions of relative absolute differences (DR ≡ |
expr1 − expr2|/[expr1 + expr2]) in the mRNA expression
of the two considered replicas, one associated to IRDM-G
and the other to N-IRDM-G.
By merging these two distributions we got the overall
median which allowed us to split the DR distribution of
IRDM-G and N-IRDM-G in two parts: the values larger,
and those smaller or equal than the median. In this way
we can construct a 2x2 contingency matrix on which
applies the Fisher’s Exact test. A statistical significant
p-value for this test would mean a distribution of DR
IRDM-G sensibly different from the N-IRDM-G one.
Estimation of the enrichment of IRDM-CGI in the
ICDM-CGI set
We considered the set of autosomal CGIs simultaneously
present in all cell lines. In this set by using QDMR, we have
identified the CGIs that were differentially methylated
among different cell lines (denoted by ICDM-CGI). In this
analysis we have adopted the most conservative threshold
value available in QDMR (SD= 0.015).
Statistical significance assessment
We considered an fdr corrected p-value threshold of
0.05 for both HBA filter GREAT analyses. The rest of
the study was conducted considering a p-value of 0.001
as statistically significant. All statistical analyses, with
the exception of GREAT and QDMR, were performed
using R ver. 2.10.1 software [35].Additional files
Additional file 1: Table S1. List of the cells used and their relevant
features.
Additional file 2: Figure S1. Observed overlap degrees show a very
different distribution than that predicted by chance. The number of
analyzed IRDM-CGIs characterized by each particular “overlap degree”,
is shown. Y-axis is in log10 scale in order to enhance the differences in
the low values range. The bars with an overlap degree of 1 correspond
to the number of IRDM-CGIs reported by one cell line only. Gray bars are
associated with observed IRDM-CGIs, and black bars correspond to the
expectation under the null hypothesis that IRDM-CGIs are chosen
randomly for each cell line. Such predictions were derived from a Monte
Carlo simulation.
Additional file 3: Table S2. IRDM-CGIs’ genomic localization, cell line
and overlap degree. For each autosomal IRDM-CGI are reported: the
coordinates (hg19), the classification in each cell line (1 if IRDM, 0
otherwise), and the corresponding overlap degree.
Additional file 4: Table S3. GREAT enrichment analysis of autosomal
common IRDM-CGIs and autosomal most common IRDM-CGIs. The
Ontology, the Term Name, the Binomial Rank, the Binomial Raw P-Value,
the Binomial FDR Q-Value, the Binomial Fold Enrichment, the Binomial
Observed Region Hits, the Binomial Region Set Coverage, the
Hypergeometric Rank, the Hypergeometric FDR Q-Value, the
Hypergeometric Fold Enrichment, the Hypergeometric Observed Gene
Hits, the Hypergeometric Total Genes and the Hypergeometric Gene Set
Coverage are reported for each term.
Additional file 5: Table S4. Overlap between ICDM-CGI and not
ICDM-CGI classes with IRDM-CGI and not IRDM-CGI classes.
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